PDCD1LG2 and melanoma: As to investigate the PD-L2 expression in predicting prognosis and immunotherapy benefits, we analyzed the online available resources by searching the Gene Expression Omnibus (GEO) database, and found that the data showing the PD-L2 expression level detected in 105 melanoma patients who received nivolumab immunotherapy in GSE91061 dataset was available for analysis.